In April 2024, the National Medical Products Administration (NMPA) approved the registration of 292 medical device products. This includes 224 domestic Class III medical devices, 37 imported Class III medical devices, 30 imported Class II medical devices.
Notable registrations include the Volcano AtheroMed Inc.’s single-use peripheral plaque excision device, Integra LifeSciences’ intracranial pressure sensor kit, Roche Diagnostics’ Factor VIII assay kit (coagulation method), Abbott Medical’s implantable deep brain neurostimulator, and Boston Scientific’s single-use magnetically guided pressure-sensing radiofrequency ablation catheter.
Other significant approvals are Bausch & Lomb’s ophthalmic surgery devices and accessories, Olympus Medical Systems’ single-use thermal biopsy forceps, Lumenis Ltd.'s holmium laser treatment machine, and Medtronic’s drug-coated peripheral balloon catheter.
The list continues with innovative products like Johnson & Johnson Surgical Vision's preloaded extended depth of focus intraocular lens, Alcon Laboratories’ vitrectomy cutters, and Medtronic’s transcatheter aortic valve system.
For detailed product names and manufacturers, please reach out to TX Medical via contact@txcro.com.
MEDTECH NEWS
NMPA Approves Registration of 292 Medical Device Products in April 2024
11 05 2024In April 2024, China's National Medical Products Administration (NMPA) approved 292 medical device products, including various innovative devices such as single-use surgical instruments, advanced diagnostic kits, and therapeutic devices from notable companies like Volcano AtheroMed Inc., Integra LifeSciences, and Abbott Medical. These approvals span across domestic and imported devices, highlighting the NMPA's focus on expanding access to advanced medical technologies.